Interaction between microRNA and KRAS in Glioblastoma

Ozal Beylerli1, Elmar Musaev2, Gervith Reyes Soto3

  • 1Central Research Laboratory, Bashkir State Medical University, Ufa, Republic of Bashkortostan, 3 Lenin Street, 450008, Russia.

PubMed

Insights

This study explores the intricate relationship between Kirsten rat sarcoma virus (KRAS) and microRNAs (miRNAs) in glioblastoma (GBM). Understanding this connection may lead to novel therapeutic strategies for this aggressive brain cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Glioblastoma (GBM) is an aggressive brain cancer with poor prognosis.
  • Mutations in the Kirsten rat sarcoma virus (KRAS) gene are common in GBM and drive cellular signaling.
  • MicroRNAs (miRNAs) are emerging as key regulators within the KRAS signaling pathway.

Purpose of the Study:

  • To investigate the interplay between KRAS and miRNAs in GBM.
  • To explore how KRAS signaling influences miRNA expression and vice versa.
  • To examine the role of this interaction in oncogene-induced senescence (OIS) and tumor progression.

Main Methods:

  • Identification of specific miRNAs targeting KRAS mRNA.
  • Analysis of downstream signaling cascades affected by KRAS and miRNAs.
  • Investigation of feedback loops between KRAS-activated pathways and miRNA levels.

Main Results:

  • Certain miRNAs were identified that directly target KRAS.
  • A feedback loop was established where KRAS activation modulates specific miRNA levels.
  • These interactions are implicated in bypassing oncogene-induced senescence (OIS).

Conclusions:

  • The miRNA-KRAS connection is a critical molecular mechanism in GBM.
  • This interaction influences cell regulation, survival, and tumor progression.
  • Targeting the miRNA-KRAS axis offers a potential avenue for innovative GBM therapies.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
3.9K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.2K